TEE
BSX icon

Tibra Equities Europe’s Boston Scientific BSX Stock Holding History

Tibra Equities Europe’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-54,900
Closed -$2.48M – 20
2019
Q4 		$2.48M Buy
+54,900
New +$2.3M 0.35% 48

Other funds holding BSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Tibra Equities Europe's BSX Position: Q1 2020 in Review

Tibra Equities Europe sold out of Boston Scientific (BSX) in Q1 2020, closing a stake of 54,900 shares — an estimated $2.48M sold.

Tibra Equities Europe first reported a position in BSX in Q4 2019 and held it in 1 quarter. The position peaked at $2.48M in Q4 2019. 800 funds tracked by Wall St. Rank hold BSX as of Q1 2020.

  • Tibra Equities Europe reported no remaining Boston Scientific position as of Q1 2020 after selling out during the quarter.
  • Tibra Equities Europe sold 54,900 Boston Scientific shares in Q1 2020, an estimated $2.48M.
  • Tibra Equities Europe first reported a position in Boston Scientific in Q4 2019 and held it in 1 quarter.
  • Tibra Equities Europe's Boston Scientific position peaked at $2.48M in Q4 2019.
  • 800 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2020.

Based on Tibra Equities Europe's 13F filing for Q1 2020, filed 15 May 2020.